Atropine Stats & Data

Atropine’s psychoactive dose-range overlaps its toxic range; fatalities and life‑threatening events have occurred at doses only modestly above those producing hallucinations. Children are especially vulnerable; 10 mg or less may be fatal in a child. In adults, severity is highly variable, with case reports spanning survival after massive ingestions to death at comparatively low doses, underscoring unpredictability. Ocular solutions are systemically absorbed (mean ~64% bioavailability of L‑hyoscyamine after topical use); ingesting or misusing eye drops has caused systemic poisoning. Anticholinergic toxidrome includes hyperthermia, tachyarrhythmias, urinary retention, ileus, anhidrosis, delirium, and realistic hallucinations; overheating is common because sweating is impaired, so hot environments and strenuous activity markedly increase danger. Acute angle‑closure glaucoma, prostatic hypertrophy/urinary obstruction, paralytic ileus, and severe cardiac disease warrant particular caution; atropine can precipitate crises in these settings. Management of overdose is medical: airway/ventilation, aggressive external cooling for hyperthermia, IV fluids, and IV benzodiazepines for agitation/seizures; physostigmine may be given only in hospital for confirmed pure anticholinergic toxicity. Avoid driving, swimming, cooking, heights, and hazardous environments during effects and for at least a day after, due to amnesia and impaired judgment. Even low concentrations used for myopia control can cause days of photophobia and near-vision blur; do not ‘redose to push through’ these effects — they are signs of antimuscarinic action, not a benign inconvenience. Plant material (Datura/Atropa) is particularly dangerous because alkaloid content varies by species, part, season, and preparation, making titration unreliable.